Squarepoint’s Definitive Healthcare DH Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q3
$184K Sell
203,073
-148,502
-42% -$122K ﹤0.01% 4096
2026
Q2
$292K Buy
351,575
+111,634
+47% +$102K ﹤0.01% 3823
2026
Q1
$295K Buy
+239,941
New +$417K ﹤0.01% 3726
2025
Q3
– Sell
-21,673
Closed -$84.5K – 4484
2025
Q2
$84.5K Buy
+21,673
New +$68.3K ﹤0.01% 4211
2023
Q3
– Sell
-13,530
Closed -$149K – 3863
2023
Q2
$149K Sell
13,530
-102,928
-88% -$1.06M ﹤0.01% 3287
2023
Q1
$1.2M Buy
116,458
+77,286
+197% +$910K ﹤0.01% 1771
2022
Q4
$430K Buy
+39,172
New +$504K ﹤0.01% 2367
2021
Q4
– Sell
-89,500
Closed -$3.83M – 3225
2021
Q3
$3.83M Buy
+89,500
New +$3.97M 0.01% 899

Other funds holding DH

Squarepoint's DH Position: Q3 2026 in Review

Squarepoint reduced its Definitive Healthcare (DH) stake by 42% in Q3 2026, selling an estimated $122K and leaving 203,073 shares worth $184K. The position accounts for ﹤0.01% of the portfolio, ranked #4096.

Squarepoint first reported a position in DH in Q3 2021 and has held it in 8 quarters since. The position peaked at $3.83M in Q3 2021. 36 funds tracked by Wall St. Rank hold DH as of Q3 2026.

  • Squarepoint held 203,073 shares of Definitive Healthcare worth $184K as of Q3 2026.
  • Squarepoint sold 148,502 Definitive Healthcare shares in Q3 2026, an estimated $122K.
  • Definitive Healthcare made up ﹤0.01% of Squarepoint's portfolio in Q3 2026, its #4096 holding.
  • Squarepoint first reported a position in Definitive Healthcare in Q3 2021 and has held it in 8 quarters since.
  • Squarepoint's Definitive Healthcare position peaked at $3.83M in Q3 2021.
  • 36 funds tracked by Wall St. Rank held Definitive Healthcare as of Q3 2026.

Based on Squarepoint's 13F filing for Q3 2026, filed 9 Nov 2026.